Connect with us

Bloomberg Technology

Ginkgo Bioworks CEO: Delta Will Be ‘Endemic Like the Flu’

Sep.17 — Ginkgo Bioworks CEO Jason Kelly speaks with Emily Chang about their historic SPAC close, charting the next step for the pandemic, and how Ginkgo’s ramped up testing for schools nationwide.

Published

on

Sep.17 — Ginkgo Bioworks CEO Jason Kelly speaks with Emily Chang about their historic SPAC close, charting the next step for the pandemic, and how Ginkgo’s ramped up testing for schools nationwide.

Continue Reading
Advertisement
8 Comments

8 Comments

  1. Sir Derty ✓

    September 17, 2021 at 11:12 pm

    spac’s are fishy

  2. Sir Derty ✓

    September 17, 2021 at 11:15 pm

    Oh look, another elizabeth holmes…
    He learned how to talk to tell you what you want.. he is a good salesman, for sure, but smart people can see through the smoke and mirrors.
    ….wow, no Jason.. This guy talking about my industry cannabis and its old news.. he did not invent yeast with THC, he is just saying things people want to buy into (401K grower for canopy growth here, he doesnt know half what I know)
    This guy reminds me of that Elizabeth girl from

    • Santiago Aguado Russo

      September 19, 2021 at 10:19 am

      Completely disagree. They have proven their technology works on several applications.

    • Lupus

      September 19, 2021 at 9:02 pm

      @Santiago Aguado Russo not only several occasions, literally scaling faster than anybody else and making a multitude of revolutionary products possible. if they were a theranos type of scam they wouldn’t be gaining customers faster they can execute.

  3. Sophie Morris

    September 17, 2021 at 11:39 pm

    var.fyi
    smashing

  4. Matt Markey

    September 17, 2021 at 11:55 pm

    Awesome work Jason! I can’t wait to look back at your body of work years from now.

  5. golgothan

    September 18, 2021 at 2:18 pm

    Can’t wait.

  6. Santiago Aguado Russo

    September 19, 2021 at 10:18 am

    The market cap is wrong…🤦🏼

    It was 15bn plus the 2.4bn in cash, so 17,4bn when it went public at $10 per share.

Leave a Reply

Cancel reply

Your email address will not be published. Required fields are marked *

Bloomberg Technology

Bloomberg Technology 03/27/2024

“Bloomberg Technology” is our daily news program focused exclusively on technology, innovation and the future of business hosted by Caroline Hyde in New York and Ed Ludlow from San Francisco.

Published

on

“Bloomberg Technology” is our daily news program focused exclusively on technology, innovation and the future of business hosted by Caroline Hyde in New York and Ed Ludlow from San Francisco.

Continue Reading

Bloomberg Technology

Databricks Doubles Down on AI Efforts to Take on Rivals

Databricks is launching its own large language model, DBRX, in an effort to help organizations understand and use their own private data to build their own AI systems. CEO and co-founder, Ali Ghodsi, says AI has driven more competition in the industry, including with it’s rival Snowflake. Ghodsi speaks with Ed Ludlow on “Bloomberg Technology.”

Published

on

Databricks is launching its own large language model, DBRX, in an effort to help organizations understand and use their own private data to build their own AI systems. CEO and co-founder, Ali Ghodsi, says AI has driven more competition in the industry, including with it’s rival Snowflake. Ghodsi speaks with Ed Ludlow on “Bloomberg Technology.”

Continue Reading

Bloomberg Technology

Operating Margins Driving Tech Earnings Recovery: Chisholm

Denise Chisholm, director of Quantitative Market Strategy at Fidelity Investments, discusses her outlook for the technology sector. She speaks with Ed Ludlow on “Bloomberg Technology.”

Published

on

Denise Chisholm, director of Quantitative Market Strategy at Fidelity Investments, discusses her outlook for the technology sector. She speaks with Ed Ludlow on “Bloomberg Technology.”

Continue Reading

Trending